Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

March 15, 2020

Study Completion Date

March 21, 2020

Conditions

Renal ImpairmentRenal InsufficiencyKidney DiseasesPharmacokinetics

Interventions

DRUG

Elafibranor

120mg oral single dose

Trial Locations (2)

Eurofins Optimed, Gières

ARENSIA Exploratory Medicine Unit, Nephrology Hospital Dr. Carol Davilla, Bucharest